Cite

HARVARD Citation

    Landi, D. et al. (2022). Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab. Neurology. 9 (3), p. . [Online]. 
  
Back to record